BKYI vs MGN

BKYI exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile stability, and lacks an Altman Z-Score, raising unquantified distress risk. The company reports severe profitability issues, including a -67.34% profit margin, -137.69% ROE, and negative earnings across all recent quarters, despite a high gross margin of 78.40%. Revenue has declined 27.7% YoY, and earnings surprises have been consistently negative in the last four quarters, with an average miss of -17.33%. The stock trades at a price-to-book of 0.80, but this is misleading given the company’s deep losses and negative equity. Analysts have a target price of $2.00, but with only one analyst covering the stock and no consensus, this is not reliable.

MGN presents as a classic value trap; while the Piotroski F-Score of 6/9 indicates stable short-term financial health and the Graham Number of $0.9 suggests deep undervaluation, these are overshadowed by catastrophic operational decay. Revenue has plummeted by 52.5% YoY and the stock has lost over 95% of its value over the last year. Despite a low P/E of 3.91 and minimal debt, the market is pricing in a terminal decline in the business model.